HIGHLIGHTS
- who: (P et al. from the Division of Virology, Department of Infection and Immunity, Jichi Medical University, Shimotsuke, Japan have published the article: No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy, in the Journal: (JOURNAL)
- what: This study compared the relative long-term risk of HCC developments after eradication of HCV between the SOF/LDV and the Sim+IFN groups.
SUMMARY
Interferon (IFN) has long been used for antiHCV therapy, and achievement of sustained virological response (SVR) by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.